FDA Approved: DRONABINOL — Supplemental Application (Wellhouse Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for dronabinol from Wellhouse Pharma, LLC (NDA205525).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• HIV Aids-related Anorexia

Drugs mentioned

• Dronabinol (dronabinol)

Snippet

SUPPL AP for DRONABINOL (DRONABINOL)